PROMIS NEUROSCIENCES INC. Payments to Fund Long-term Loans to Related Parties
PROMIS NEUROSCIENCES INC. (PMN) reported Payments to Fund Long-term Loans to Related Parties of $296.59 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow
us-gaap:PaymentsToFundLongtermLoansToRelatedParties · last filed 2023-11-14
- PROMIS NEUROSCIENCES INC. payments to fund long-term loans to related parties for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- PROMIS NEUROSCIENCES INC. payments to fund long-term loans to related parties for the quarter ending 2023-06-30 was $148.76K.
- PROMIS NEUROSCIENCES INC. payments to fund long-term loans to related parties for the quarter ending 2023-03-31 was $147.83K.
- PROMIS NEUROSCIENCES INC. payments to fund long-term loans to related parties for the quarter ending 2022-09-30 was $255.34K.
| Period end | Payments to Fund Long-term Loans to Related Parties 3 month | Payments to Fund Long-term Loans to Related Parties 6 month | Payments to Fund Long-term Loans to Related Parties 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $148.76K derived: sum of 2 quarters · filed 2023-11-14 | $296.59K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $148.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $296.59K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $147.83K 10-Q · filed 2023-05-15 | ||
| 2022-09-30 | $255.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $255.34K derived: sum of 2 quarters · filed 2023-11-14 | $255.34K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |